CCME Global share news and announcements
BSE: 514336Pharmaceuticals & BiotechnologySmall Cap
Share price at the BSE close on 23 Oct 2026. Previous close ₹31.81.
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies.
- ₹137 Cr2,307th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit.
- Lossover the last 12 months
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet.
- Shares changed
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it. The filing of 14 Aug 2026
- −3.5%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet. The filing of 14 Aug 2026
- −2.2%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026. The filing of 29 May 2026
- 0.00
- Volume, BSEVolume. Shares traded on the last trading day.
- 1,296
CCME Global share news and announcements
551 announcements, routine notices left out, newest first. Page 2 of 12.
Mar 2026
6 Mar · Adoption Of New Line Of Business By The Company.
6 Mar · Announcement under Regulation 30 (LODR)-Amendments to Memorandum & Articles of Association
Feb 2026
14 Feb · Results
14 Feb · Results
11 Feb · Board meeting
Meeting on 14 Feb 2026: quarterly results
Jan 2026
28 Jan · Announcement under Regulation 30 (LODR)-Issue of Securities
22 Jan · Board meeting
Meeting on 28 Jan 2026: increase in authorised capital and preferential issue of shares19 Jan · Announcement under Regulation 30 (LODR)-Change of Company Name
19 Jan · Management
19 Jan · Board meeting
8 Jan · Regulation 31A (10) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 Relating To Reclassification Of 'Promoter/Promoter Group Category' To 'Public Category' Pursuant To Open Offer.
Dec 2025
31 Dec · Management
23 Dec · Post-Offer Public Announcement
Nov 2025
25 Nov · Pre-offer Advertisement and Corrigendum to the Detailed Public Statement
24 Nov · Updates on Open Offer
22 Nov · Updates on Open Offer
22 Nov · Updates on Open Offer
14 Nov · Business
14 Nov · Results
6 Nov · Board meeting
Meeting on 14 Nov 2025: quarterly results
Sep 2025
30 Sep · Meeting
30 Sep · Meeting
3 Sep · Meeting
Aug 2025
29 Aug · Board meeting
7 Aug · Board meeting
Meeting on 14 Aug 2025: quarterly results
Jun 2025
May 2025
29 May · Business